Apellis to Move IPF Immunotherapy into Testing with $47.1M Series D Financing

Apellis to Move IPF Immunotherapy into Testing with $47.1M Series D Financing

Apellis Pharmaceuticals, Inc., recently announced that it has completed a $47.1 million Series D preferred stock financing, which will be used to advance clinical trials into the company’s complement immunotherapy programs for diseases that include idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). The complement system is part of…

The Patient Voice: Bryan, IPF Patient

https://vimeo.com/133560286 This is a video shared by PatientsLikeMe in July, 2015. In it, you can watch idiopathic pulmonary fibrosis patient, Bryan Kincaid, talk about his life with IPF. Bryan became a patient of Patients Like Me in 2013, but unfortunately, in 2014, Bryan passed away due to complications…

Marilyn’s Pulmonary Fibrosis Story

“Marylin was diagnosed with PF and needed a lung transplant, but due to her age many centers wouldn’t perform the procedure. The Temple Lung Center gave her the life-saving transplant that she needed.” Learn more about pulmonary fibrosis and lung transplants: https://bit.ly/1lfMsiZ…

Lung Exercises: Healing Your Breath

In this video from 2010, the youtube channel Lung Exercises shares some tips and demonstrates some exercises for people with lung cancer, COPD and other breathing problems, like pulmonary fibrosis. Learn more about pulmonary fibrosis: https://bit.ly/1lfMsiZ   Note: Pulmonary Fibrosis News is strictly a news and information website about…